![](https://www.diabetesnews.com/wp-content/uploads/2014/03/bones-150x150.jpg)
Authors conclude that treatment with Onglyza for type 2 diabetes in older patients was not related with an increased risk of fractures as this was shown by a study encompassing a large population sample. However, an interesting finding between the duration of diabetes and increased risk of bone fracture was discovered, which requires further studies to determine contributing factors.